1. Doughty M, Mehta R, Bruckman D, et al. Acute myocardial infarction in the young: the University of Michigan experience. Am Heart J 2002;143:56–62.
2. Fournier JA, Sánchez A, Quero J, Fernández-Cortacero JA, González-Barrero A. Myocardial infarction in men aged 40 years or less: a prospective clinical-angiographic study. Clin Cardiol 1996;19:631–636.
3. Moccetti T, Malacrida R, Pasotti E, et al. Epidemiologic variables and outcome of 1972 young patients with acute myocardial infarction: data from the GISSI-2 database: investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2). Arch Intern Med 1997;157:865–869.
4. Shiraishi J, Kohno Y, Yamaguchi S, et al. Acute myocardial infarction in young Japanese adults. Circ J 2005;69:1454–1458.
5. Trzos E, Uznańska B, Rechciński T, Krzemińska-Pakuła M, Bugała M, Kurpesa M. Myocardial infarction in young people. Cardiol J 2009;16:307–311.
6. Killip T 3rd, Kimball JT. Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients. Am J Cardiol 1967;20:457–464.
7. Scanlon PJ, Faxon DP, Audet AM, et al. ACC/AHA guidelines for coronary angiography: areport of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography): developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardol 1999;33:1756–1824.
8. Kini AS. Coronary angiography, lesion classification and severity assessment. Cardiol Clin 2006;24:153–162.
9. Roe MT, Ohman EM, Pollack CV Jr, et al. Changing the model of care for patients with acute coronary syndromes. Am Heart J 2003;146:605–612.
10. Nikus KC, Eskola MJ, Virtanen VK, et al. Mortality of patients with acute coronary syndromes still remains high: a follow-up study of 1188 consecutive patients admitted to a university hospital. Ann Med 2007;39:63–71.
11. Song YB, Hahn JY, Kim JH, et al. Comparison of angiographic and other findings and mortality in non-ST-segment elevation versus ST-segment elevation myocardial infarction in patients undergoing early invasive intervention. Am J Cardiol 2010;106:1397–1403.
12. Montalescot G, Dallongeville J, Van Belle E, et al. STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry). Eur Heart J 2007;28:1409–1417.
14. Medina HM, Cannon CP, Zhao X, et al. Quality of acute myocardial infarction care and outcomes in 33,997 patients aged 80 years or older: findings from Get With The Guidelines- Coronary Artery Disease (GWTG-CAD). Am Heart J 2011;162:283–290.
15. Morillas P, Bertomeu V, Pabón P, et al. Characteristics and outcome of acute myocardial infarction in young patients. The PRIAMHO II study. Cardiology 2007;107:217–225.
16. Cho JY, Jeong MH, Ahn Y, et al. Predictive factors of major adverse cardiac events and clinical outcomes of acute myocardial infarction in young Korean patients. Korean Circ J 2008;38:161–169.
17. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 2007;28:2525–2538.
18. Castelli WP. Cardiovascular disease and multifactorial risk: challenge of the 1980s. Am Heart J 1983;106(5 Pt 2):1191–1200.
19. Skelding KA, Mehta LS, Pica MC, et al. Primary percutaneous interventions for acute myocardial infarction in octogenarians: a single-center experience. Clin Cardiol 2002;25:363–366.
20. Sakai K, Nakagawa Y, Kimura T, et al. Comparison of results of coronary angioplasty for acute myocardial infarction in patients > or =75 years of age versus patients <75 years of age. Am J Cardiol 2002;89:797–800.
21. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988;332:78–81.
22. Kwon TG, Bae JH, Jeong MH, et al. N-terminal pro-B-typenatriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention. Int J Cardiol 2009;133:173–178.
23. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease: Stent Restenosis Study Investigators. N Engl J Med 1994;331:496–501.
24. Costa MA, Simon DI. Molecular basis of restenosis and drug-eluting stents. Circulation 2005;111:2257–2273.
25. Nordmann AJ, Hengstler P, Harr T, Young J, Bucher HC. Clinical outcomes of primary stenting versus balloon angioplasty in patients with myocardial infarction: a meta- analysis of randomized controlled trials. Am J Med 2004;116:253–262.
26. Hong YJ, Jeong MH, Choi YH, et al. Differences in intravascular ultrasound findings in culprit lesions in infarct-related arteries between ST segment elevation myocardial infarction and non-ST segment elevation myocardial infarction. J Cardiol 2010;56:15–22.
27. Laarman GJ, Suttorp MJ, Dirksen MT, et al. Paclitaxel- eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med 2006;355:1105–1113.
28. Valgimigli M, Percoco G, Malagutti P, et al. Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial. JAMA 2005;293:2109–2117.
29. Berg K. A new serum type system in main: the LP System. Acta Pathol Microbiol Scand 1963;59:369–382.
30. Barre DE. The molecular nature and consequences of lipoprotein (a)'s association with platelets. Protein Pept Lett 2007;14:839–842.